Richard F. Hank

Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TRβ subtype-selective thyromimetics

Robert L. Dow, Steven R. Schneider, Ernest S. Paight et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 93 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Novel Series +7

An Optimized Process for Formation of 2,4-Disubstituted Imidazoles from Condensation of Amidines and α-Haloketones

Bryan Li, Charles K.‐F. Chiu, Richard F. Hank et al. · Organic Process Research & Development · 2002 · 46 citations

Engineering, Potassium Bicarbonate, Vigorous Reflux +9

The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of Type 2 diabetes mellitus

Jeffrey A. Pfefferkorn, Meihua Tu, Kevin J. Filipski et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 44 citations · Full text

Medicinal Chemistry, Diabetes Management, Biochemistry +11

Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor

Daniel W. Kung, Steven B. Coffey, Ryan M. Jones et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 26 citations · Full text

Biochemistry, Functional Selectivity, Medicine +9

Structure–activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists

Richard L. Elliott, Robert M. Oliver, Janet A. LaFlamme et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 26 citations · Full text

Molecular Pharmacology, Drug Target, Medicine +5